A detailed history of Redwood Investments, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Redwood Investments, LLC holds 3,484 shares of NVO stock, worth $366,760. This represents 0.13% of its overall portfolio holdings.

Number of Shares
3,484
Previous 3,950 11.8%
Holding current value
$366,760
Previous $563,000 26.47%
% of portfolio
0.13%
Previous 0.17%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$119.07 - $145.42 $55,486 - $67,765
-466 Reduced 11.8%
3,484 $414,000
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $4,084 - $5,436
40 Added 1.02%
3,950 $507,000
Q4 2023

Jan 19, 2024

SELL
$87.78 - $105.45 $24,929 - $29,947
-284 Reduced 6.77%
3,910 $404,000
Q3 2023

Oct 24, 2023

BUY
$90.94 - $199.54 $192,065 - $421,428
2,112 Added 101.44%
4,194 $381,000
Q2 2023

Jul 24, 2023

BUY
$155.98 - $172.65 $324,750 - $359,457
2,082 New
2,082 $336,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Redwood Investments, LLC Portfolio

Follow Redwood Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redwood Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redwood Investments, LLC with notifications on news.